Last edition
News about "Mayo Clinic"
Illumina Unveils Whole-Genome Sequencing Solution for Sensitive MRD Detection
Illumina has launched the first distributed Whole-Genome Sequencing (WGS) solution for highly sensitive Molecular Residual Disease (MRD) research, enabling faster and more flexible detection of the disease during and after treatment while expanding its next-generation oncology sequencing portfolio.
Mayo Clinic | 02/06/2026 | By News Bureau
NVIDIA Teams Up with Industry Leaders to Accelerate Genomics and Drug Discovery
Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.
Mayo Clinic | 15/01/2025 | By Aishwarya | 508
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy